2Gravitt P,Coutlee F,Iftner T,et al.New technologies in cervical cancer screening.Vaccine,2008,26 Suppl 10:K42-52.
3Anttila A,Pukkala E,S(o)dennan B,et al.Effect of organized screening on cervical cancer incidence and mortality in Finland,1963-1995; recent increase in cervical cancer incidence.Int J Cancer,1999,83:59-65.
4Belinson J,Qiao YL,Pretorius R,et al.Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shanxi Province Cervical Cancer Screening Study.Int J Gynecol Cancer,1999,9:411-417.
5Belinson J,Qiao YL,Pretorius R,et al.Shanxi Province Cervical Cancer Screening Study; a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.Gynecol Oncol,2001,83:439-444.
6Arbyn M,Sasieni P,Meijer CJ,et al.Chapter 9:Clinical applications of HPV testing:a summary of meta-analyses.Vaccine,2006,24 Suppl 3:S3/78-89.
7Moss S,Gray A,Legood R,et al.Effect of testing for human papillomavirus as a triage during screening for cervical cancer:observational before and after study.BMJ,2006,332:83-85.
8Cuzick J,Szarewski A,Mesher D,et al.Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology:results from the Hammersmith study.Int J Cancer,2008,122:2294-2300.
9Shi JF,Belinson JL,Zhao FH,et al.Human papillomavirus testing for cervical cancer screening:results from a 6-year prospective study in rural China.Am J Epidemiol,2009,170:708-716.
10Goldie SJ,Gaffikin L,Goldhaber-Fiebert JD,et al.Cost-effectiveness of cervical-cancer screening in five developing countries.N Engl J Med,2005,353:2158-2168.
